Hydralazine Use in Hypertensive Emergencies and Special Populations

Intravenous Administration for Hypertensive Emergencies

Initial dose: Begin with 10 mg of hydralazine given as a slow IV infusion (maximum initial dose 20 mg); repeat every 4–6 hours as needed to achieve blood‑pressure control. The American College of Cardiology (ACC) advises this regimen but notes hydralazine’s unpredictable response and prolonged action make it unsuitable as a first‑line agent. 1
Onset of effect: Systolic and diastolic blood pressure typically begins to fall within 10–30 minutes after IV administration. 1
Duration of effect: The hypotensive effect generally persists for 2–4 hours. 1

ACC/AHA recommendation: For hypertensive emergencies, the ACC/AHA guidelines preferentially endorse titratable agents such as nicardipine, labetalol, or clevidipine because they provide more predictable and rapidly adjustable blood‑pressure reductions; hydralazine is not recommended as a first‑line drug. 1

Gradual reduction: Aim for no more than a 25 % decrease in mean arterial pressure during the first hour of treatment. 3
Intermediate target: If the patient remains stable, achieve a blood‑pressure goal of approximately 160/100 mm Hg within 2–6 hours. 3
Final normalization: Complete blood‑pressure normalization should be pursued cautiously over the subsequent 24–48 hours. 3

Maternal/fetal adverse effects: Frequent or high‑dose hydralazine use in pregnant patients has been linked to maternal hypotension, headaches, and abnormal fetal heart‑rate tracings. 6
Dosing for severe hypertension in pregnancy: Administer 5 mg IV or IM initially, followed by 5–10 mg IV every 20–40 minutes, not exceeding a cumulative dose of 20 mg. 6
Alternative infusion regimen: A continuous infusion of 0.5–10 mg per hour may be used when rapid titration is required. 6
Onset in pregnancy: Blood‑pressure lowering effect appears within 10–20 minutes after administration. 6
Therapeutic hierarchy: Hydralazine is considered a second‑line option after labetalol or nifedipine for severe hypertension in pregnancy, per European Society of Cardiology (ESC) guidance. 7

Fixed‑dose combination initiation: Start a fixed‑dose combination of hydralazine 20 mg plus isosorbide dinitrate 37.5 mg taken three times daily. 8
Target maintenance dose: Titrate to hydralazine 75 mg plus isosorbide dinitrate 40 mg three times daily (total daily hydralazine 225 mg, isosorbide dinitrate 120 mg). 8
Alternative titration schedule: Hydralazine 25–50 mg administered 3–4 times daily, with gradual increase up to a maximum total daily dose of 300 mg, can be employed when the fixed‑dose combination is unavailable. 8

Avoid first‑line use: Do not select hydralazine as the initial agent for hypertensive emergencies when titratable medications such as nicardipine or labetalol are accessible. 1